Generative AI

At CES 2026, Ubicept's new toolkit promises to let AI see clearly in the dark and at high speed, ushering in a new era for robotics and autonomous cars.

Lucid crushed its 2025 production goals with a huge Q4 surge, but a widening gap between cars built and sold raises serious questions about demand.

Fintech firm Movemint's rebrand signals a major shift for banks, focusing on embedded finance and personalized experiences to drive measurable growth.

Founder Chuck Cohn pours millions more into his ed-tech firm, a bold move that signals deep confidence despite a slumping stock and cautious analysts.

With a hot obesity pipeline and a key neurology asset, Nxera Pharma's J.P. Morgan talk is a crucial test of its plan for global leadership.

AUKEY unveils a 200W GaN charging hub with retractable cables and 25W Qi2, leading a new lineup designed to declutter the modern professional's desk.

With stunning clinical data for its miv-cel therapy, Kyverna is set to outline a new era for autoimmune treatment at the J.P. Morgan conference.

Dnsys scores three CES 2026 Innovation Awards for its Z1 exoskeleton, merging advanced human augmentation with gaming culture for the consumer market.

With blockbuster sales from VYJUVEK, Krystal Biotech heads to J.P. Morgan with investors eager for news on its global growth and ambitious pipeline.

A new partnership between etherWhere and AsiaRF promises ultra-low power, high-precision location tracking for everything from police cameras to Wi-Fi 7.

Off The Hook's new luxury division leverages AI and an integrated model to secure ~$100M in listings and close 22 deals in its explosive first quarter.

A new integration brings Ceres AI's insights directly into the John Deere Operations Center, tackling data fragmentation for growers and insurers alike.

With deep institutional and private sector tech experience, new CEO Andrew Bercich is tasked with guiding the U.S. workforce system through a pivotal era.

Amid a capacity crisis, a new model blending AI with human oversight gains traction, promising efficiency without sacrificing the crucial element of patient care.

China's ETF market had a record 2025, fueled by AI breakthroughs and state support. A look at the boom, the leaders, and the risks ahead.

Circle Pharma will unveil its pipeline of novel oral macrocycle drugs targeting elusive cancer drivers at the influential J.P. Morgan Healthcare Conference.

With 163% order growth and new AI tools, Pipe17 is redefining post-purchase logistics. Is this the future of how e-commerce gets delivered?

A global RFA leader unveils a new identity, reflecting a strategic shift from pure engineering to a focus on the patient's quality of life.

A humanoid robot named Nylo will manage IntBot's CES booth entirely alone, a high-stakes, unscripted test of AI's readiness for the real world.

COOLFLY debuts its Aura Smart Bird Feeder at CES 2026, blending high-end design, a modular camera, and a 'Bird-tok' social community.